Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chromatin Assembly and Disassembly | 27 | 2023 | 635 | 7.360 |
Why?
|
Chromosomal Proteins, Non-Histone | 19 | 2023 | 736 | 6.500 |
Why?
|
Chromatin | 25 | 2023 | 2934 | 3.180 |
Why?
|
Transcription Factors | 36 | 2023 | 12208 | 2.830 |
Why?
|
Sarcoma, Synovial | 6 | 2021 | 167 | 2.560 |
Why?
|
Nucleosomes | 8 | 2023 | 494 | 1.980 |
Why?
|
Oncogene Proteins, Fusion | 8 | 2022 | 1581 | 1.820 |
Why?
|
Multiprotein Complexes | 6 | 2023 | 1119 | 1.380 |
Why?
|
Mammals | 10 | 2023 | 1143 | 1.350 |
Why?
|
Nuclear Proteins | 14 | 2023 | 5853 | 1.170 |
Why?
|
Rhabdoid Tumor | 2 | 2018 | 212 | 1.090 |
Why?
|
Disease | 2 | 2020 | 680 | 0.880 |
Why?
|
Neoplasm Proteins | 5 | 2020 | 3703 | 0.830 |
Why?
|
Liposarcoma, Myxoid | 1 | 2022 | 67 | 0.820 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2021 | 8428 | 0.810 |
Why?
|
DNA-Binding Proteins | 11 | 2023 | 9648 | 0.760 |
Why?
|
Adenosine Triphosphatases | 3 | 2021 | 839 | 0.750 |
Why?
|
Heterochromatin | 3 | 2017 | 296 | 0.720 |
Why?
|
Histones | 6 | 2022 | 2599 | 0.690 |
Why?
|
Models, Molecular | 5 | 2022 | 5456 | 0.660 |
Why?
|
Ubiquitins | 1 | 2020 | 384 | 0.650 |
Why?
|
Proto-Oncogene Proteins | 4 | 2020 | 4554 | 0.640 |
Why?
|
Neoplasms | 11 | 2023 | 21683 | 0.630 |
Why?
|
HEK293 Cells | 8 | 2020 | 4204 | 0.630 |
Why?
|
Repressor Proteins | 3 | 2020 | 3023 | 0.620 |
Why?
|
Lymphoma | 6 | 2013 | 1877 | 0.610 |
Why?
|
Sarcoma | 3 | 2018 | 1897 | 0.610 |
Why?
|
Genetic Fitness | 1 | 2018 | 121 | 0.580 |
Why?
|
Lifting | 1 | 2016 | 56 | 0.540 |
Why?
|
Developmental Biology | 1 | 2016 | 76 | 0.530 |
Why?
|
Granulocytes | 1 | 2017 | 548 | 0.510 |
Why?
|
p300-CBP Transcription Factors | 1 | 2016 | 147 | 0.510 |
Why?
|
Protein Subunits | 4 | 2021 | 959 | 0.510 |
Why?
|
Cell Line, Tumor | 17 | 2022 | 16689 | 0.510 |
Why?
|
Meningeal Neoplasms | 2 | 2022 | 1241 | 0.500 |
Why?
|
DNA Helicases | 7 | 2023 | 859 | 0.490 |
Why?
|
Protein Interaction Mapping | 1 | 2018 | 627 | 0.480 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2016 | 294 | 0.470 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2013 | 693 | 0.460 |
Why?
|
Meningioma | 1 | 2022 | 1209 | 0.450 |
Why?
|
Serine Endopeptidases | 1 | 2018 | 1072 | 0.440 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2016 | 670 | 0.420 |
Why?
|
Soft Tissue Neoplasms | 2 | 2020 | 1363 | 0.410 |
Why?
|
Complement Activation | 1 | 2013 | 453 | 0.400 |
Why?
|
Animals | 36 | 2023 | 168757 | 0.390 |
Why?
|
Protein Binding | 8 | 2021 | 9386 | 0.380 |
Why?
|
Central Nervous System Neoplasms | 3 | 2013 | 895 | 0.360 |
Why?
|
Mutation | 11 | 2023 | 29786 | 0.360 |
Why?
|
Genome, Human | 2 | 2019 | 4420 | 0.330 |
Why?
|
Enhancer Elements, Genetic | 4 | 2019 | 1341 | 0.330 |
Why?
|
Adenosine Triphosphate | 4 | 2022 | 2025 | 0.310 |
Why?
|
Hematopoiesis | 1 | 2017 | 2072 | 0.300 |
Why?
|
SOXB1 Transcription Factors | 2 | 2021 | 284 | 0.280 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2017 | 2214 | 0.260 |
Why?
|
Humans | 56 | 2023 | 744343 | 0.260 |
Why?
|
Lymphoma, Non-Hodgkin | 3 | 2012 | 1381 | 0.240 |
Why?
|
RNA Interference | 4 | 2019 | 2889 | 0.220 |
Why?
|
Cell Proliferation | 5 | 2019 | 10481 | 0.210 |
Why?
|
Tumor Suppressor Proteins | 3 | 2020 | 2849 | 0.210 |
Why?
|
Oncogenes | 3 | 2021 | 1265 | 0.210 |
Why?
|
Virus Internalization | 2 | 2023 | 501 | 0.200 |
Why?
|
Liver Neoplasms | 1 | 2017 | 4253 | 0.200 |
Why?
|
Prostatic Neoplasms | 3 | 2018 | 11124 | 0.200 |
Why?
|
Mutation, Missense | 2 | 2020 | 2564 | 0.190 |
Why?
|
Gene Knockdown Techniques | 2 | 2018 | 1655 | 0.190 |
Why?
|
Genes, Tumor Suppressor | 2 | 2017 | 1097 | 0.190 |
Why?
|
Structural Homology, Protein | 1 | 2020 | 91 | 0.190 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2021 | 223 | 0.190 |
Why?
|
Histone Code | 1 | 2021 | 163 | 0.180 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2021 | 307 | 0.180 |
Why?
|
Brain Neoplasms | 4 | 2009 | 8863 | 0.180 |
Why?
|
Epidermal Growth Factor | 1 | 2022 | 708 | 0.180 |
Why?
|
DNA | 4 | 2022 | 7301 | 0.170 |
Why?
|
Spliceosomes | 1 | 2019 | 110 | 0.170 |
Why?
|
Gene Knockout Techniques | 2 | 2020 | 809 | 0.170 |
Why?
|
Genetic Predisposition to Disease | 2 | 2018 | 17446 | 0.160 |
Why?
|
Cyclin-Dependent Kinase 9 | 1 | 2018 | 66 | 0.160 |
Why?
|
Adenovirus E1A Proteins | 1 | 2018 | 76 | 0.160 |
Why?
|
Carcinoma, Medullary | 1 | 2019 | 123 | 0.160 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2013 | 9239 | 0.160 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 1 | 2018 | 160 | 0.160 |
Why?
|
Brachytherapy | 1 | 2005 | 1248 | 0.150 |
Why?
|
Mutant Proteins | 1 | 2019 | 500 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2018 | 318 | 0.150 |
Why?
|
Cryoelectron Microscopy | 1 | 2020 | 571 | 0.150 |
Why?
|
Catalysis | 1 | 2019 | 761 | 0.150 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2017 | 105 | 0.150 |
Why?
|
Genes, Essential | 1 | 2018 | 183 | 0.150 |
Why?
|
Genetic Complementation Test | 1 | 2017 | 562 | 0.140 |
Why?
|
Transcriptional Activation | 1 | 2023 | 1783 | 0.140 |
Why?
|
Promoter Regions, Genetic | 2 | 2018 | 5867 | 0.140 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2017 | 121 | 0.140 |
Why?
|
Embryonic Stem Cells | 2 | 2021 | 1294 | 0.140 |
Why?
|
Lymphoma, T-Cell | 1 | 2018 | 299 | 0.140 |
Why?
|
RNA-Binding Protein EWS | 1 | 2017 | 216 | 0.140 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2020 | 5172 | 0.140 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2017 | 249 | 0.140 |
Why?
|
Protein Conformation | 2 | 2022 | 4011 | 0.130 |
Why?
|
Ubiquitination | 1 | 2020 | 1012 | 0.130 |
Why?
|
Transcription, Genetic | 3 | 2018 | 7722 | 0.120 |
Why?
|
RNA Splicing | 1 | 2019 | 907 | 0.120 |
Why?
|
Mice | 14 | 2023 | 81183 | 0.120 |
Why?
|
Mutagenesis | 1 | 2018 | 1266 | 0.120 |
Why?
|
Rare Diseases | 1 | 2019 | 553 | 0.120 |
Why?
|
Complement C5b | 1 | 2013 | 9 | 0.120 |
Why?
|
Histone Acetyltransferases | 1 | 2016 | 336 | 0.120 |
Why?
|
Epigenesis, Genetic | 2 | 2018 | 3647 | 0.120 |
Why?
|
Complement C3a | 1 | 2013 | 69 | 0.120 |
Why?
|
Injections, Intraventricular | 1 | 2013 | 230 | 0.120 |
Why?
|
HeLa Cells | 1 | 2019 | 3128 | 0.110 |
Why?
|
Chemokine CXCL13 | 1 | 2013 | 54 | 0.110 |
Why?
|
Injections, Spinal | 1 | 2013 | 303 | 0.110 |
Why?
|
Antibodies | 1 | 2021 | 2460 | 0.110 |
Why?
|
Heterozygote | 1 | 2019 | 2804 | 0.110 |
Why?
|
RNA Polymerase II | 1 | 2016 | 551 | 0.110 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2019 | 1338 | 0.110 |
Why?
|
Organoids | 1 | 2018 | 701 | 0.110 |
Why?
|
Killer Cells, Natural | 1 | 2021 | 2133 | 0.110 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2013 | 323 | 0.100 |
Why?
|
Developmental Disabilities | 1 | 2020 | 1456 | 0.100 |
Why?
|
Phenotype | 2 | 2020 | 16365 | 0.100 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13695 | 0.100 |
Why?
|
Host-Pathogen Interactions | 1 | 2020 | 1477 | 0.100 |
Why?
|
Receptors, Estrogen | 1 | 2020 | 2187 | 0.100 |
Why?
|
Point Mutation | 1 | 2016 | 1623 | 0.100 |
Why?
|
Mass Spectrometry | 1 | 2018 | 2203 | 0.100 |
Why?
|
Drosophila | 1 | 2018 | 1491 | 0.100 |
Why?
|
DNA, Neoplasm | 1 | 2016 | 1758 | 0.090 |
Why?
|
Prostate | 1 | 2018 | 1774 | 0.090 |
Why?
|
DNA Replication | 1 | 2016 | 1399 | 0.090 |
Why?
|
Gene Expression Profiling | 3 | 2018 | 9438 | 0.090 |
Why?
|
Saccharomyces cerevisiae | 1 | 2020 | 2752 | 0.090 |
Why?
|
Binding Sites | 1 | 2018 | 6114 | 0.090 |
Why?
|
Tissue Distribution | 1 | 2013 | 2327 | 0.090 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2727 | 0.090 |
Why?
|
Cell Cycle Proteins | 2 | 2020 | 3462 | 0.080 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2012 | 640 | 0.080 |
Why?
|
Mice, Inbred NOD | 3 | 2020 | 1878 | 0.080 |
Why?
|
STAT6 Transcription Factor | 1 | 2009 | 199 | 0.080 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6622 | 0.080 |
Why?
|
Models, Genetic | 1 | 2019 | 3494 | 0.080 |
Why?
|
DNA Modification Methylases | 1 | 2009 | 206 | 0.080 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1903 | 0.080 |
Why?
|
Mice, Nude | 2 | 2019 | 3689 | 0.080 |
Why?
|
Cell Nucleus | 1 | 2017 | 2969 | 0.080 |
Why?
|
Adenocarcinoma | 1 | 2005 | 6364 | 0.080 |
Why?
|
DNA Methylation | 2 | 2019 | 4286 | 0.080 |
Why?
|
Protein Processing, Post-Translational | 1 | 2016 | 1990 | 0.080 |
Why?
|
Amino Acid Sequence | 1 | 2019 | 13815 | 0.080 |
Why?
|
Interleukin-10 | 1 | 2013 | 1200 | 0.080 |
Why?
|
DNA Repair Enzymes | 1 | 2009 | 349 | 0.070 |
Why?
|
Luminescent Measurements | 1 | 2009 | 405 | 0.070 |
Why?
|
Gene Frequency | 1 | 2013 | 3588 | 0.070 |
Why?
|
Methotrexate | 1 | 2012 | 1727 | 0.070 |
Why?
|
Dacarbazine | 1 | 2009 | 566 | 0.070 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9734 | 0.070 |
Why?
|
Genomics | 2 | 2019 | 5720 | 0.070 |
Why?
|
Cell Polarity | 1 | 2009 | 645 | 0.070 |
Why?
|
Interleukin-4 | 1 | 2009 | 1147 | 0.060 |
Why?
|
Neoplasm Transplantation | 2 | 2019 | 2085 | 0.060 |
Why?
|
Genetic Testing | 1 | 2018 | 3444 | 0.060 |
Why?
|
Proteins | 1 | 2020 | 6103 | 0.060 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2020 | 2649 | 0.060 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2023 | 91 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9274 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2013 | 2942 | 0.050 |
Why?
|
Prognosis | 3 | 2020 | 29063 | 0.050 |
Why?
|
Urinary Bladder | 1 | 2009 | 1172 | 0.050 |
Why?
|
Male | 11 | 2020 | 350118 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Ethanol | 1 | 2009 | 1342 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4262 | 0.050 |
Why?
|
Proteomics | 2 | 2013 | 3638 | 0.050 |
Why?
|
Signal Transduction | 3 | 2022 | 23403 | 0.050 |
Why?
|
Immunoblotting | 2 | 2020 | 1682 | 0.050 |
Why?
|
Radiation Injuries | 1 | 2009 | 1180 | 0.050 |
Why?
|
Female | 13 | 2022 | 380194 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12261 | 0.050 |
Why?
|
Liver Regeneration | 1 | 2022 | 210 | 0.050 |
Why?
|
Antibody Affinity | 1 | 2021 | 254 | 0.050 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2023 | 377 | 0.050 |
Why?
|
Genetic Markers | 1 | 2006 | 2634 | 0.050 |
Why?
|
GPI-Linked Proteins | 1 | 2021 | 434 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2020 | 3557 | 0.040 |
Why?
|
Prostate-Specific Antigen | 2 | 2009 | 2494 | 0.040 |
Why?
|
Vero Cells | 1 | 2020 | 485 | 0.040 |
Why?
|
Treatment Failure | 1 | 2005 | 2618 | 0.040 |
Why?
|
Lymphoma, B-Cell | 2 | 2021 | 931 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2020 | 170 | 0.040 |
Why?
|
HMGB1 Protein | 1 | 2020 | 133 | 0.040 |
Why?
|
GATA3 Transcription Factor | 1 | 2020 | 157 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13102 | 0.040 |
Why?
|
Haploinsufficiency | 1 | 2020 | 328 | 0.040 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2018 | 103 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2020 | 21746 | 0.040 |
Why?
|
Guanosine Triphosphate | 1 | 2018 | 321 | 0.040 |
Why?
|
Azepines | 1 | 2020 | 336 | 0.040 |
Why?
|
Coronavirus | 1 | 2020 | 158 | 0.040 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2018 | 194 | 0.040 |
Why?
|
Receptors, IgG | 1 | 2021 | 582 | 0.040 |
Why?
|
Genes, Dominant | 1 | 2020 | 880 | 0.040 |
Why?
|
Immunoprecipitation | 1 | 2020 | 905 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2020 | 3597 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2021 | 538 | 0.040 |
Why?
|
Immunoenzyme Techniques | 2 | 2013 | 1799 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2013 | 19229 | 0.040 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2017 | 212 | 0.040 |
Why?
|
Transcription Initiation Site | 1 | 2017 | 196 | 0.040 |
Why?
|
Alcohol Drinking | 1 | 2009 | 3966 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2021 | 728 | 0.030 |
Why?
|
Survival Rate | 3 | 2020 | 12788 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 625 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2021 | 20822 | 0.030 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2021 | 789 | 0.030 |
Why?
|
Antioxidants | 1 | 2023 | 1663 | 0.030 |
Why?
|
Neuroglia | 1 | 2020 | 927 | 0.030 |
Why?
|
Microsatellite Repeats | 1 | 2017 | 802 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2020 | 57776 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5535 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2020 | 1970 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2018 | 873 | 0.030 |
Why?
|
Triazoles | 1 | 2020 | 911 | 0.030 |
Why?
|
Middle Aged | 7 | 2020 | 213383 | 0.030 |
Why?
|
Zebrafish Proteins | 1 | 2020 | 1005 | 0.030 |
Why?
|
Macrophages | 1 | 2009 | 5655 | 0.030 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2017 | 893 | 0.030 |
Why?
|
Ubiquitin | 1 | 2019 | 852 | 0.030 |
Why?
|
Rabbits | 1 | 2020 | 4894 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2005 | 8642 | 0.030 |
Why?
|
Infusions, Intraventricular | 1 | 2012 | 36 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2018 | 987 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 12072 | 0.030 |
Why?
|
Small Molecule Libraries | 1 | 2018 | 720 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2018 | 1364 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2018 | 3129 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2021 | 3206 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2018 | 3701 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2020 | 1708 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2021 | 2866 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2018 | 1836 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2020 | 1708 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2021 | 2416 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1526 | 0.020 |
Why?
|
Drosophila Proteins | 1 | 2020 | 1703 | 0.020 |
Why?
|
Down-Regulation | 1 | 2018 | 3002 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2012 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2019 | 2440 | 0.020 |
Why?
|
Cell Cycle | 1 | 2019 | 2967 | 0.020 |
Why?
|
Epigenomics | 1 | 2016 | 903 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2016 | 1375 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2183 | 0.020 |
Why?
|
Gene Expression | 1 | 2023 | 7799 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14722 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2016 | 1462 | 0.020 |
Why?
|
Chemotaxis | 1 | 2013 | 607 | 0.020 |
Why?
|
Aged | 4 | 2020 | 163280 | 0.020 |
Why?
|
Adult | 5 | 2020 | 214055 | 0.020 |
Why?
|
Sirolimus | 1 | 2017 | 1564 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3505 | 0.020 |
Why?
|
Zebrafish | 1 | 2020 | 2994 | 0.020 |
Why?
|
Goserelin | 1 | 2009 | 129 | 0.020 |
Why?
|
Cell Survival | 1 | 2018 | 5882 | 0.020 |
Why?
|
Infant | 2 | 2020 | 35136 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2915 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2016 | 1788 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6538 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6933 | 0.020 |
Why?
|
Antithrombin III | 1 | 2007 | 128 | 0.020 |
Why?
|
Child, Preschool | 2 | 2020 | 41006 | 0.020 |
Why?
|
Mice, SCID | 1 | 2013 | 2716 | 0.020 |
Why?
|
Genetic Loci | 1 | 2017 | 2575 | 0.020 |
Why?
|
Eye Neoplasms | 1 | 2009 | 313 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2017 | 1632 | 0.020 |
Why?
|
Fibroblasts | 1 | 2017 | 4161 | 0.020 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2007 | 180 | 0.020 |
Why?
|
Drug Therapy | 1 | 2009 | 497 | 0.020 |
Why?
|
Cell Line | 1 | 2020 | 15997 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 503 | 0.020 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2009 | 547 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4751 | 0.020 |
Why?
|
Genetic Variation | 1 | 2020 | 6544 | 0.020 |
Why?
|
Blotting, Western | 1 | 2013 | 5179 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2013 | 6314 | 0.020 |
Why?
|
Adolescent | 3 | 2020 | 85781 | 0.020 |
Why?
|
Leukemia, Myeloid | 1 | 2007 | 707 | 0.020 |
Why?
|
Recurrence | 1 | 2016 | 8340 | 0.010 |
Why?
|
Chromatography, Liquid | 1 | 2007 | 976 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10638 | 0.010 |
Why?
|
Kidney | 1 | 2019 | 7186 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2009 | 12959 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 19905 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2009 | 1275 | 0.010 |
Why?
|
Child | 2 | 2020 | 77709 | 0.010 |
Why?
|
Radiotherapy | 1 | 2009 | 1533 | 0.010 |
Why?
|
Neurons | 1 | 2020 | 9338 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10180 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 29144 | 0.010 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2009 | 1524 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 21827 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3870 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2009 | 1620 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39050 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2013 | 13033 | 0.010 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2007 | 1378 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 40561 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 40075 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 56430 | 0.010 |
Why?
|
Immunotherapy | 1 | 2009 | 4445 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2009 | 20129 | 0.000 |
Why?
|
Risk Factors | 1 | 2009 | 72290 | 0.000 |
Why?
|